2018
DOI: 10.1016/j.immuni.2018.10.003
|View full text |Cite
|
Sign up to set email alerts
|

Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
85
0
2

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(90 citation statements)
references
References 0 publications
3
85
0
2
Order By: Relevance
“…Expression of influenza virus NS1, vaccinia virus E3L, reovirus σ3 and Nodamura virus (NoV) B2 proteins inhibits RNAi in plants and/or insect cells (Lichner et al, ; Bucher et al, ; Delgadillo et al, ; Li et al, ). In mammalian cells, a plethora of mammalian virus‐encoded VSRs, including primate foamy virus type 1 (PFV‐1) Tas, NoV B2, HCV core, IAV NS1, HIV Tat, Ebola VP35, VP30 and VP40, CoV N, SARS‐CoV 7a, YFV capsid, DENV NS4B, human enterovirus 71 (HEV 71) 3A and adenovirus virus‐associated RNA I (VA1), can reduce shRNA/siRNA‐mediated knockdown of reporter genes (Table ) (Lu & Cullen, ; Andersson et al, ; Lecellier et al, ; Sullivan & Ganem, ; Wang et al, ; Haasnoot et al, ; Chen et al, ; de Vries et al, ; Karjee et al, ; Fabozzi et al, ; Kakumani et al, ; Cui et al, ; Samuel et al, ; Qiu et al, ). Most viral proteins identified thus far that display VSR activity share the ability to bind dsRNA and mutations that affect their dsRNA‐binding domain block VSR activity, arguing that their principal mode of action is sequestration of dsRNA from Dicer (Table ).…”
Section: Viral Determinants Of Antiviral Rnaimentioning
confidence: 99%
See 2 more Smart Citations
“…Expression of influenza virus NS1, vaccinia virus E3L, reovirus σ3 and Nodamura virus (NoV) B2 proteins inhibits RNAi in plants and/or insect cells (Lichner et al, ; Bucher et al, ; Delgadillo et al, ; Li et al, ). In mammalian cells, a plethora of mammalian virus‐encoded VSRs, including primate foamy virus type 1 (PFV‐1) Tas, NoV B2, HCV core, IAV NS1, HIV Tat, Ebola VP35, VP30 and VP40, CoV N, SARS‐CoV 7a, YFV capsid, DENV NS4B, human enterovirus 71 (HEV 71) 3A and adenovirus virus‐associated RNA I (VA1), can reduce shRNA/siRNA‐mediated knockdown of reporter genes (Table ) (Lu & Cullen, ; Andersson et al, ; Lecellier et al, ; Sullivan & Ganem, ; Wang et al, ; Haasnoot et al, ; Chen et al, ; de Vries et al, ; Karjee et al, ; Fabozzi et al, ; Kakumani et al, ; Cui et al, ; Samuel et al, ; Qiu et al, ). Most viral proteins identified thus far that display VSR activity share the ability to bind dsRNA and mutations that affect their dsRNA‐binding domain block VSR activity, arguing that their principal mode of action is sequestration of dsRNA from Dicer (Table ).…”
Section: Viral Determinants Of Antiviral Rnaimentioning
confidence: 99%
“…Finally, the HEV71‐encoded protein 3A inhibits shRNA‐mediated silencing in mammalian cells, as well as antiviral RNAi in insect cells, and suppresses Dicer‐mediated biogenesis of siRNAs by binding and sequestering long dsRNA in vitro (Qiu et al, ). A point mutation that inactivates 3A's VSR activity reduces viral replication in somatic cells and in suckling mice.…”
Section: Viral Determinants Of Antiviral Rnaimentioning
confidence: 99%
See 1 more Smart Citation
“…dmDcr-1 has a degenerate helicase domain and is an ATP-independent enzyme (10), while dmDcr-2, with dedicated antiviral roles (1113), has a conserved helicase domain that hydrolyzes ATP (1417). Under certain conditions Homo sapiens Dicer-1 (hsDcr-1) also generates viral siRNAs (18, 19). However, despite conservation of its helicase domain, hsDcr-1 does not hydrolyze ATP in vitro (20), and its helicase domain is not implicated in viral siRNA biogenesis in vivo (19).…”
mentioning
confidence: 99%
“…Cumulative evidences have emerged in support of functional RNAi‐dependent antiviral immunity in mammals (Berkhout, ; Jeang, ; Qiu et al, ). According to this view, the very establishment of infection over cellular defence requires production of extremely potent and efficient VSRs.…”
Section: Discussionmentioning
confidence: 99%